*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Immune/NNP Response/NNP Corp./NNP ]
has/VBZ 
[ 29/CD employees/NNS ]
,/, 
[ no/DT marketable/JJ product/NN ]
,/, 
[ no/DT sales/NNS ]
and/CC 
[ no/DT earnings/NNS ]
./. 

But/CC if/IN 
[ all/DT ]
goes/VBZ well/RB for/IN 
[ the/DT company/NN ]
,/, 
[ it/PRP ]
soon/RB will/MD have/VB 
[ a/DT stock-market/JJ valuation/NN ]
of/IN as/RB much/JJ as/IN 
[ $/$ 135/CD million/CD ]
,/, 
[ thanks/NNS ]
to/TO 
[ Wall/NNP Street/NNP ]
./. 

======================================

[ The/DT new-issues/JJ equity/NN market/NN ]
,/, 
[ it/PRP ]
appears/VBZ ,/, is/VBZ heating/VBG up/RP ./. 

[ Many/JJ ]
of/IN 
[ the/DT players/NNS ]
think/VBP 
[ the/DT success/NN ]
of/IN 
[ Immune/NNP Response/NNP ]
of/IN 
[ La/NNP Jolla/NNP ]
,/, 
[ Calif./NNP ]
,/, 
[ which/WDT ]
is/VBZ already/RB circulating/VBG 
[ its/PRP$ preliminary/JJ prospectus/NN ]
,/, could/MD mark/VB 
[ a/DT turning/VBG point/NN ]
for/IN 
[ the/DT entire/JJ market/NN ]
./. 

======================================

If/IN 
[ Immune/NNP Response/NNP 's/POS offering/NN fares/VBZ ]
well/RB ,/, 
[ many/JJ other/JJ young/JJ technology/NN companies/NNS ]
now/RB effectively/RB barred/VBN from/IN 
[ going/VBG public/JJ ]
might/MD be/VB able/JJ to/TO take/VB 
[ the/DT plunge/NN ]
,/, 
[ investment/NN bankers/NNS ]
and/CC 
[ investors/NNS ]
say/VBP ./. 

[ The/DT Immune/NNP Response/NNP offering/NN ]
,/, still/RB subject/JJ to/TO 
[ clearance/NN ]
by/IN 
[ the/DT Securities/NNP ]
and/CC 
[ Exchange/NNP Commission/NNP ]
,/, is/VBZ tentatively/RB scheduled/VBN for/IN 
[ late/JJ October/NNP ]
./. 

======================================

Although/IN 
[ it/PRP ]
still/RB lacks/VBZ 
[ a/DT marketable/JJ product/NN ]
,/, 
[ the/DT company/NN ]
has/VBZ 
[ a/DT glamorous/JJ concept/NN ]

[ that/WDT ]
could/MD prove/VB to/TO be/VB enormously/RB 
[ lucrative/JJ ]
--/: 
[ an/DT AIDS/NNP vaccine/NN ]
./. 

Moreover/RB ,/, 
[ the/DT celebrated/VBN father/NN ]
of/IN 
[ the/DT polio/NN vaccine/NN ]
,/, 
[ 74-year-old/JJ Jonas/NNP Salk/NNP ]
,/, is/VBZ 
[ chairman/NN ]
of/IN 
[ the/DT company/NN 's/POS scientific/JJ advisory/JJ board/NN ]
./. 

``/`` 
[ That/DT ]
's/VBZ 
[ the/DT kind/NN ]
of/IN 
[ sizzle/NN investors/NNS ]
long/VBP to/TO buy/VB ,/, ''/'' says/VBZ 
[ Gordon/NNP Ramseier/NNP ]
,/, 
[ chief/JJ executive/JJ officer/NN ]
of/IN 
[ Immunetech/NNP Pharmaceuticals/NNP ]
,/, 
[ a/DT San/NNP Diego/NNP drug/NN maker/NN ]
./. 

======================================

[ Wall/NNP Street/NNP underwriters/NNS ]
,/, led/VBN by/IN 
[ Merrill/NNP Lynch/NNP ]
&/CC 
[ Co./NNP ]
,/, hope/VBP to/TO raise/VB as/IN much/RB 
[ $/$ 45/CD million/CD ]
by/IN selling/VBG about/RB 
[ one-third/JJ ]
of/IN 
[ Immune/NNP Response/NNP 's/POS shares/NNS ]
to/TO 
[ the/DT public/NN ]
at/IN 
[ $/$ 11/CD ]
to/TO 
[ $/$ 13/CD each/DT ]
./. 

``/`` Pretty/RB expensive/JJ ,/, ''/'' says/VBZ 
[ Stuart/NNP Weisbrod/NNP ]
,/, 
[ a/DT biotechnology/NN analyst/NN ]
for/IN 
[ Prudential-Bache/NNP Securities/NNP ]
,/, 
[ New/NNP York/NNP ]
./. 

[ One/CD influential/JJ East/NNP Coast/NNP mutual-fund/JJ manager/NN ]
says/VBZ 
[ many/JJ institutions/NNS ]
are/VBP avoiding/VBG --/: as/RB too/RB risky/JJ --/: 
[ investments/NNS ]
in/IN 
[ biotechnology/NN companies/NNS ]

[ that/WDT ]
lack/VBP 
[ marketable/JJ products/NNS ]
./. 

Although/IN 
[ a/DT biotechnology/NN investor/NN ]

[ himself/PRP ]
,/, 
[ he/PRP ]
has/VBZ yet/RB to/TO make/VB up/RP 
[ his/PRP$ mind/NN ]
whether/IN to/TO buy/VB 
[ Immune/NNP Response/NNP shares/NNS ]
./. 

======================================

[ James/NNP B./NNP Glavin/NNP ]
,/, 
[ chief/JJ executive/JJ officer/NN ]
of/IN 
[ Immune/NNP Response/NNP ]
,/, could/MD n't/RB be/VB reached/VBN for/IN 
[ comment/NN ]
./. 

[ Charles/NNP J./NNP Cashion/NNP ]
,/, 
[ vice/NN president/NN ]
and/CC 
[ chief/JJ financial/JJ officer/NN ]
,/, said/VBD of/IN 
[ the/DT proposed/VBN price/NN ]
:/: ``/`` 
[ We/PRP ]
have/VBP n't/RB just/RB pulled/VBN 
[ the/DT numbers/NNS ]
out/IN of/IN 
[ the/DT air/NN ]
./. 

[ We/PRP ]
would/MD n't/RB be/VB seeking/VBG 
[ the/DT price/NN ]
if/IN 
[ we/PRP ]
did/VBD n't/RB think/VB 
[ it/PRP ]
was/VBD 
[ the/DT right/JJ one/CD ]
./. 

''/'' 
[ A/DT Merrill/NNP Lynch/NNP spokesman/NN ]
in/IN 
[ New/NNP York/NNP ]
had/VBD 
[ no/DT immediate/JJ comment/NN ]
./. 

======================================

[ It/PRP ]
's/VBZ too/RB early/JJ to/TO tell/VB how/WRB 
[ the/DT underwriters/NNS ]
will/MD fare/VB ;/: 
[ some/DT meetings/NNS ]
between/IN 
[ Immune/NNP Response/NNP officials/NNS ]
and/CC 
[ potential/JJ investors/NNS ]
are/VBP n't/RB even/RB due/JJ to/TO take/VB 
[ place/NN ]
until/IN 
[ mid-October/JJR ]
./. 

But/CC succeed/VB or/CC fail/VB ,/, 
[ the/DT attempted/VBN underwriting/NN ]
may/MD have/VB 
[ great/JJ market/NN significance/NN ]
./. 

``/`` 
[ It/PRP ]
's/VBZ 
[ a/DT bellwether/NN ]
for/IN whether/IN 
[ the/DT markets/NNS ]
are/VBP going/VBG to/TO be/VB receptive/JJ to/TO funding/VBG 
[ emerging/VBG technology/NN ]
,/, 
[ something/NN ]

[ they/PRP ]
have/VBP n't/RB done/VBN for/IN 
[ the/DT last/JJ two/CD years/NNS ]
,/, ''/'' says/VBZ 
[ Peter/NNP Drake/NNP ]
,/, 
[ a/DT biotechnology/NN analyst/NN ]
with/IN 
[ Vector/NNP Securities/NNP International/NNP Inc./NNP ]
,/, 
[ a/DT Chicago/NNP securities/NNS firm/NN ]
./. 

======================================

If/IN 
[ the/DT offering/NN ]
succeeds/VBZ ,/, ``/`` 
[ it/PRP ]
could/MD create/VB 
[ a/DT lot/NN ]
of/IN 
[ hope/NN ]
for/IN 
[ many/JJ biotechnology/NN companies/NNS ]
looking/VBG for/IN 
[ capital/NN ]
,/, ''/'' says/VBZ 
[ Frederick/NNP J./NNP Dotzler/NNP ]
,/, managing/VBG 
[ general/JJ partner/NN ]
of/IN 
[ Medicus/NNP Venture/NNP Partners/NNP ]
,/, 
[ Menlo/NNP Park/NNP ]
,/, 
[ Calif/NNP ]
./. 

Even/RB before/IN 
[ the/DT outcome/NN ]
is/VBZ clear/JJ ,/, 
[ the/DT offering/NN ]
is/VBZ prompting/VBG 
[ some/DT small/JJ technology/NN companies/NNS ]
to/TO inquire/VB about/IN 
[ their/PRP$ chances/NNS ]
of/IN 
[ going/VBG public/NN ]
,/, adds/VBZ 
[ Sanford/NNP Robertson/NNP ]
,/, 
[ a/DT principal/NN ]
of/IN 
[ Robertson/NNP ]
,/, 
[ Stephens/NNP ]
&/CC 
[ Co./NNP ]
,/, 
[ a/DT San/NNP Francisco/NNP investment/NN bank/NN ]
./. 

======================================

For/IN much/JJ of/IN 
[ this/DT year/NN ]
,/, 
[ such/JJ chances/NNS ]
were/VBD poor/JJ indeed/RB ./. 

``/`` 
[ Every/DT time/NN underwriters/NNS ]
have/VBP tried/VBN to/TO bring/VB out/RP 
[ something/NN a/DT little/RB racy/JJ ]
,/, 
[ it/PRP ]

[ has/VBZ n't/RB ]
done/VBN well/RB ,/, ''/'' says/VBZ 
[ Michael/NNP Murphy/NNP ]
,/, 
[ editor/NN ]
of/IN 
[ California/NNP Technology/NNP Stock/NNP Letter/NNP ]
,/, 
[ San/NNP Francisco/NNP ]
./. 

[ IDD/NNP Information/NNP Services/NNP ]
,/, 
[ a/DT New/NNP York/NNP research/NN concern/NN ]
,/, says/VBZ 
[ initial/JJ public/JJ offerings/NNS ]
in/IN 
[ the/DT first/JJ nine/CD months/NNS ]
raised/VBD about/RB 
[ $/$ 8.5/CD billion/CD ]
,/, 
[ a/DT sharp/JJ drop/NN ]
from/IN nearly/RB 
[ $/$ 19/CD billion/CD ]
in/IN 
[ the/DT year-earlier/JJ period/NN ]
./. 

======================================

Although/IN 
[ some/DT technology/NN companies/NNS ]
have/VBP been/VBN among/IN 
[ those/DT ]

[ going/VBG public/JJ ]

[ this/DT year/NN ]
,/, ``/`` 
[ the/DT high-tech/JJ market/NN ]
is/VBZ 
[ a/DT pale/JJ shadow/NN ]
of/IN 
[ what/WP ]

[ it/PRP ]
was/VBD in/IN 
[ 1983/CD ]
,/, ''/'' 
[ the/DT speculative/JJ peak/NN ]
,/, says/VBZ 
[ Norman/NNP G./NNP Fosback/NNP ]
,/, 
[ editor/NN ]
of/IN 
[ New/NNP Issues/NNP newsletter/NN ]
,/, 
[ Fort/NNP Lauderdale/NNP ]
,/, 
[ Fla/NNP ]
./. 

======================================

After/IN 
[ 1983/CD ]
,/, and/CC especially/RB following/VBG 
[ the/DT October/NNP 1987/CD stock-market/NN crash/NN ]
,/, 
[ many/JJ investors/NNS ]
turned/VBD away/RB from/IN 
[ small/JJ companies/NNS ]
as/IN 
[ investments/NNS ]
or/CC ,/, at/IN 
[ minimum/NN ]
,/, insisted/VBD on/IN 
[ high/JJ quality/NN ]
,/, usually/RB defined/VBN as/IN 
[ a/DT record/NN ]
of/IN growing/VBG 
[ profits/NNS ]
./. 

``/`` 
[ Investors/NNS ]
have/VBP been/VBN discriminating/VBG in/IN 
[ their/PRP$ pick/NN ]
of/IN 
[ new/JJ issues/NNS ]
,/, ''/'' says/VBZ 
[ Edward/NNP Mathias/NNP ]
,/, managing/VBG 
[ director/NN ]
of/IN 
[ T./NNP Rowe/NNP Price/NNP Associates/NNP ]
,/, 
[ a/DT Baltimore/NNP manager/NN ]
of/IN 
[ mutual/JJ funds/NNS ]
./. 

======================================

With/IN 
[ the/DT stock/NN market/NN ]
robust/JJ once/IN again/RB ,/, 
[ some/DT institutional/JJ investors/NNS ]
began/VBD returning/VBG to/TO 
[ the/DT new-issues/JJ market/NN ]
early/RB 
[ this/DT year/NN ]
,/, says/VBZ 
[ Richard/NNP L./NNP Franyo/NNP ]
,/, 
[ the/DT investment/NN banking/NN chief/NN ]
for/IN 
[ Alex/NNP ]
./. 

[ Brown/NNP ]
&/CC 
[ Sons/NNP Inc./NNP ]
,/, 
[ Baltimore/NNP ]
./. 

[ One/CD result/NN ]
was/VBD that/IN 
[ Network/NNP General/NNP Corp./NNP ]
,/, 
[ a/DT Mountain/NNP View/NNP ]
,/, 
[ Calif./NNP ]
,/, 
[ maker/NN ]
of/IN 
[ diagnostic/JJ tools/NNS ]
for/IN 
[ data-communications/NNS systems/NNS ]
,/, easily/RB raised/VBN 
[ $/$ 17/CD million/CD ]
in/IN 
[ its/PRP$ initial/JJ public/JJ offering/NN ]
in/IN 
[ February/NNP ]
./. 

[ The/DT shares/NNS ]
have/VBP more/RBR than/IN doubled/VBN since/IN then/RB ,/, stirring/VBG 
[ further/JJ interest/NN ]
in/IN 
[ the/DT new-issues/JJ market/NN ]
,/, 
[ Mr./NNP Franyo/NNP ]
says/VBZ ./. 

======================================

Among/IN 
[ companies/NNS ]
hoping/VBG to/TO exploit/VB 
[ the/DT situation/NN ]
by/IN 
[ going/VBG public/JJ ]
by/IN 
[ year-end/JJ ]
are/VBP 
[ Electronic/NNP Arts/NNP ]
,/, 
[ a/DT San/NNP Mateo/NNP ]
,/, 
[ Calif./NNP ]
,/, 
[ maker/NN ]
of/IN 
[ entertainment/NN software/NN ]
for/IN 
[ computers/NNS ]
;/: 
[ Lattice/NNP Semiconductor/NNP Corp./NNP ]
,/, 
[ Beaverton/NNP ]
,/, 
[ Ore./NNP ]
;/: and/CC 
[ ImmunoGen/NNP Inc./NNP ]
,/, 
[ a/DT Cambridge/NNP ]
,/, 
[ Mass./NNP ]
,/, 
[ biotechnology/NN company/NN ]
./. 

[ MIPS/NNP Computer/NNP Systems/NNP Inc./NNP ]
,/, 
[ Sunnyvale/NNP ]
,/, 
[ Calif./NNP ]
,/, plans/VBZ 
[ a/DT public/NN ]
offering/NN 
[ early/JJ next/JJ year/NN ]
./. 

======================================

As/IN for/IN 
[ Immune/NNP Response/NNP ]
,/, 
[ which/WDT ]

[ Dr./NNP Salk/NNP ]
helped/VBD found/VBN ,/, 
[ the/DT company/NN ]
says/VBZ 
[ it/PRP ]
is/VBZ going/VBG 
[ public/JJ ]
because/IN 
[ it/PRP ]
needs/VBZ 
[ capital/NN ]
to/TO offset/VB anticipated/VBN 
[ operating/NN losses/NNS ]
as/IN 
[ it/PRP ]
develops/VBZ 
[ its/PRP$ first/JJ products/NNS ]
./. 

Although/IN 
[ the/DT company/NN ]
has/VBZ already/RB received/VBN more/JJR than/IN 
[ $/$ 17/CD million/CD ]
from/IN 
[ private/JJ placements/NNS ]
--/: 
[ the/DT investors/NNS ]
include/VBP 
[ Rorer/NNP Corp./NNP ]
and/CC 
[ Colgate/NNP Palmolive/NNP Co./NNP ]
--/: 
[ it/PRP ]
expects/VBZ to/TO spend/VB much/RB more/JJR than/IN that/DT before/IN seeing/VBG 
[ a/DT profit/NN ]
./. 

======================================

[ The/DT company/NN ]
says/VBZ 
[ its/PRP$ first/JJ product/NN ]
under/IN 
[ development/NN ]
,/, 
[ an/DT AIDS/NNP vaccine/NN ]
,/, is/VBZ based/VBN on/IN 
[ a/DT scientific/JJ approach/NN ]
first/RB suggested/VBN by/IN 
[ Dr./NNP Salk/NNP ]
./. 

As/IN 
[ he/PRP ]
had/VBD done/VBN with/IN 
[ polio/NN ]
,/, 
[ Dr./NNP Salk/NNP ]
proposed/VBD using/VBG 
[ whole/JJ ]
but/CC inactivated/VBN 
[ AIDS/NNP viruses/NNS ]
to/TO inoculate/VB 
[ people/NNS ]
already/RB infected/VBN ./. 

But/CC 
[ some/DT other/JJ scientists/NNS ]
say/VBP 
[ such/JJ viruses/NNS ]
are/VBP unsafe/JJ in/IN 
[ humans/NNS ]
,/, and/CC 
[ Dr./NNP Salk/NNP 's/POS approach/NN ]
is/VBZ by/IN 
[ no/DT means/NN ]

[ a/DT certain/JJ winner/NN ]
./. 

======================================

Still/RB ,/, because/IN of/IN 
[ the/DT Salk/NNP name/NN ]
and/CC 
[ track/NN record/NN ]
,/, 
[ Immune/NNP Response/NNP shares/NNS ]
may/MD have/VB 
[ great/JJ appeal/NN ]
to/TO 
[ individual/JJ investors/NNS ]
--/: 
[ which/WDT ]

[ Merrill/NNP Lynch/NNP ]
,/, 
[ the/DT chief/JJ underwriter/NN ]
,/, is/VBZ particularly/RB adept/JJ at/IN reaching/VBG ./. 

``/`` 
[ It/PRP ]
's/VBZ 
[ the/DT kind/NN ]
of/IN 
[ thing/NN ]

[ the/DT public/NN ]
is/VBZ interested/VBN in/IN ,/, ''/'' 
[ James/NNP McCamant/NNP ]
,/, 
[ editor/NN ]
of/IN 
[ Medical/NNP Technology/NNP Stock/NNP Letter/NNP ]
,/, 
[ Berkeley/NNP ]
,/, 
[ Calif./NNP ]
,/, says/VBZ of/IN 
[ the/DT pending/VBG offering/NN ]
./. 

[ The/DT new-issues/JJ market/NN ]
is/VBZ strong/JJ enough/RB that/IN 
[ the/DT offering/NN ]
``/`` is/VBZ probably/RB 
[ doable/JJ ]
,/, ''/'' 
[ Mr./NNP McCamant/NNP ]
says/VBZ ./. 

======================================

[ Others/NNS ]
caution/VBP ,/, however/RB ,/, that/IN 
[ no/DT name/NN ]
--/: even/RB 
[ Jonas/NNP Salk/NNP 's/POS ]
--/: can/MD guarantee/VB 
[ a/DT company/NN 's/POS success/NN ]
./. 

In/IN 
[ 1983/CD ]
,/, 
[ Symbion/NNP Inc./NNP ]
of/IN 
[ Salt/NNP Lake/NNP City/NNP ]
 (/( then/RB called/VBD 
[ Kolff/NNP Medical/NNP Inc./NNP ]
 )/) ,/, went/VBD 
[ public/JJ ]
at/IN 
[ $/$ 12.50/CD ]

[ a/DT share/NN ]
./. 

[ The/DT company/NN ]
had/VBD 
[ appeal/NN ]
largely/RB because/IN 
[ its/PRP$ president/NN ]
,/, 
[ Robert/NNP K./NNP Jarvik/NNP ]
,/, had/VBD implanted/VBN 
[ an/DT artificial/NN heart/NN ]
in/IN 
[ patient/NN Barney/NNP Clark/NNP ]
,/, 
[ whose/WP$ name/NN ]
became/VBD 
[ a/DT household/NN word/NN ]
./. 

But/CC 
[ the/DT artificial-heart/JJ market/NN ]
failed/VBD to/TO develop/VB as/IN projected/VBN ./. 

[ Symbion/NNP shares/NNS ]
now/RB trade/VBP at/IN about/RB 
[ $/$ 2/CD ]
and/CC 
[ Dr./NNP Jarvik/NNP ]
has/VBZ long/RB since/IN left/VBN 
[ the/DT company/NN ]
./. 
